Join
Live feed
·
INSIDERFilingvia Quantisnow
Aktis Oncology Inc. logo

Director Segal Lloyd Mitchell converted options into 19,631 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AKTS· Aktis Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTS (Aktis Oncology Inc.) and more on Quantisnow.

Director Segal Lloyd Mitchell converted options into 19,631 shares (SEC Form 4) | Quantisnow